RESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation beads plus immunotherapy could shrink liver tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of radiation beads (SIRT) and two immunotherapy drugs (tremelimumab and durvalumab) before surgery is safe and effective for people with liver cancer that can be removed. About 20 participants will receive the treatment and then have …
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Jiping Wang, MD, PhD • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New PET tracer could sharpen liver cancer detection
Diagnosis Recruiting nowThis study is testing a new imaging agent called 18F-FSPG to see if it can better detect liver cancer on PET scans. About 110 adults with liver tumors will receive the tracer before surgery or transplant, and the results will be compared with standard scans and tissue analysis. T…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 11, 2026 20:40 UTC